Medical Technology

@xconomy.com 4 years ago

Backed by $100M, Praxis Aims to Turn Epilepsy Research Into New Neuro Drugs

@xconomy.com 4 years ago

Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More

@xconomy.com 4 years ago

VenBio Partners Bags $394M to Back More Medicine-Making Biotechs

@xconomy.com 4 years ago

Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More

@xconomy.com 4 years ago

EnClear Therapies Nets $10M to Test Neuro Disease ‘Dialysis’ Device

@xconomy.com 4 years ago

Review: Inside the House of Lies at Theranos

@xconomy.com 5 years ago

Bio Roundup: Generic Drugs Graft, ASCO Ahead, ElevateBio Rises & More

@xconomy.com 5 years ago

DermaClip Ramps Up for U.S. Sales Push of Wound-Healing Device

@xconomy.com 5 years ago

Beta Bionics Secures $63M as AI-Driven “Pancreas” Heads to Key Tests

@xconomy.com 5 years ago

From Immigration to Taxes, Execs Talk Trump Effect on Innovation

@xconomy.com 5 years ago

Boston Tech Watch: Gradifi, Numerated, Jibo, Corvus, Botkeeper

@xconomy.com 5 years ago

Synthorx Files for IPO to Advance Enhanced Cytokine Drugs

@xconomy.com 5 years ago

Circulation CEO Talks Sale to LogistiCare & Amazon’s Healthcare Play

@xconomy.com 5 years ago

In Boston’s Shadow, Rhode Island Fights for Life Science Jobs, Respect

@xconomy.com 5 years ago

Virtual Physical Therapy Firms Reflexion and MindMaze Probe Markets

@xconomy.com 6 years ago

CAR-T’s Launch, Payers vs. Gene Therapy & Photos From “What’s Hot”

@xconomy.com 6 years ago

Iora Health Goes Big With $100M to Advance Collaborative Care Model